# Phase 10 Verification: Shared Contracts Audit

**Status:** Passed  
**Completed:** 2026-06-01  
**Branch:** `main`  
**Tip before closeout docs:** `74d8288`

## Source Of Truth

Phase 10 implementation, QA, and review agents read:

- `/Users/matt/Documents/Claude/Projects/FlashQuery/flashquery-product/Product/Cate/Upstream Sync Report (30-May-2026)/Upstream Sync Requirements.md`
- `/Users/matt/Documents/Claude/Projects/FlashQuery/flashquery-product/Product/Cate/Upstream Sync Report (30-May-2026)/Upstream Sync Test Plan.md`

## Plan Status

| Plan | Status | Evidence |
|------|--------|----------|
| 10.1 Contract inventory and proof audit | Pass | `10-01-SUMMARY.md`, `evidence/contracts/NOTES.md` |
| 10.2 Security/session assertion hardening | Pass | `10-02-SUMMARY.md`, `evidence/security/NOTES.md` |
| 10.3 Evidence, cumulative gate, and closeout | Pass | `evidence/final/`, `10-UAT.md`, this file |

## Requirement Coverage

| Requirement | Status | Evidence |
|-------------|--------|----------|
| REQ-005 | Pass | Token sanitization/session persistence proof in `evidence/security/NOTES.md`; full unit suite; focused `T-E-004` persistence E2E |
| REQ-006 | Pass | Public probe/private bearer proof in `src/main/ipc/flashquery.test.ts` and `evidence/security/NOTES.md` |
| REQ-008 | Pass | Exact IPC channel and collision proof in `src/shared/ipc-channels.test.ts`, `src/main/ipc/flashquery.test.ts`, and `evidence/contracts/NOTES.md` |
| REQ-009 | Pass | Pre-merge fixture compatibility in `src/renderer/lib/session.test.ts`; explicit type-field proof in `src/shared/types.test.ts`; focused persistence E2E |
| REQ-010 | Pass | `CATE_E2E` preload helper gate in `src/preload/index.test.ts`; renderer harness gate documented in `evidence/contracts/NOTES.md` |
| REQ-019 | Pass | T-A-012 conflict review addendum remains present in Phase 8/9 verification and is re-audited in `evidence/contracts/NOTES.md` |
| REQ-024 | Pass | Build, typecheck, unit, and focused E2E logs in `evidence/final/` |
| REQ-025 | Pass | Cumulative suite passes after Phase 10 remediation |

## Test Coverage

| Test ID | Status | Evidence |
|---------|--------|----------|
| T-U-001 | Pass | Exact channel string assertions in `src/main/ipc/flashquery.test.ts` |
| T-U-002 | Pass | Collision-free channel assertion in `src/shared/ipc-channels.test.ts` |
| T-U-003 | Pass | `npm run typecheck` and typed API declarations in `src/shared/electron-api.d.ts` |
| T-U-004 | Pass | Sanitization assertions in `src/shared/types.test.ts` |
| T-U-005 | Pass | Public/private auth assertions in `src/main/ipc/flashquery.test.ts` |
| T-U-006 | Pass | Supporting body-only write assertions in `src/renderer/panels/EditorPanel.test.tsx` and `src/main/ipc/flashquery.test.ts` |
| T-U-007 | Pass | `src/preload/index.test.ts`; focused persistence E2E title also includes T-E-007 crosswalk |
| T-U-008 | Pass | `src/renderer/lib/session.test.ts` pre-merge fixture |
| T-U-009 | Pass | `src/shared/types.test.ts` explicit shape retention test |
| T-E-004 | Pass | `evidence/final/test-e2e-persistence.log`; `e2e/flashquery-persistence.spec.ts` title contains `T-E-004 persistence` |
| T-A-002 | Pass | `evidence/final/test.log` and focused E2E log |
| T-A-004 | Pass | `evidence/final/typecheck.log` |
| T-A-012 | Pass | Phase 8 conflict review addendum and Phase 9 verification, rechecked in `evidence/contracts/NOTES.md` |

## Automated Matrix

| Command | Log | Exit Code | Status |
|---------|-----|-----------|--------|
| `npm run build` | `evidence/final/build.log` | 0 | Pass |
| `npm run typecheck` | `evidence/final/typecheck.log` | 0 | Pass |
| `npm test` | `evidence/final/test.log` | 0 | Pass, 63 files / 596 passed / 3 skipped |
| `npm run test:e2e -- e2e/flashquery-persistence.spec.ts` | `evidence/final/test-e2e-persistence.log` | 0 | Pass, 1 Playwright test |

## Notes

- The full unit log includes existing jsdom/act warnings and one logged drag test error from an expected failure-path assertion, but Vitest exits 0 and reports all files passing.
- No command was skipped, so no non-run rationale is needed.

## Remaining Follow-Ups

None for Phase 10.
